Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

Jennifer R. Grandis, D J Tweardy · PubMed · 1993 · 859 citations

Medicine, Oncology, Pathology +10

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Denis Soulières, Neil Senzer, Everett E. Vokes et al. · Journal of Clinical Oncology · 2003 · 808 citations · Full text

Medicine, Oncology, Pharmacology +11

ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.

Devarajan Karunagaran, Eldad Tzahar, Roger R. Beerli et al. · The EMBO Journal · 1996 · 674 citations · Full text

Medicine, Molecular Biology, Oncology +12

Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Ezra E.W. Cohen, Fred Rosen, Walter M. Stadler et al. · Journal of Clinical Oncology · 2003 · 607 citations

Medicine, Oncology, Pharmacotherapy +13

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.

O. Dassonville, J. L. Formento, M Francoual et al. · Journal of Clinical Oncology · 1993 · 413 citations

Medicine, Oncology, Cancer Pharmacology +9